{"id":5996,"date":"2024-05-22T10:31:04","date_gmt":"2024-05-22T10:31:04","guid":{"rendered":"https:\/\/www.angelssante.fr\/?p=5996"},"modified":"2024-07-17T10:21:28","modified_gmt":"2024-07-17T10:21:28","slug":"angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma","status":"publish","type":"post","link":"https:\/\/www.angelssante.fr\/en\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\/","title":{"rendered":"Angels Sant\u00e9 takes part in HEPHAISTOS-Pharma's \u20ac10.3M fund-raising round (FR)"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"5996\" class=\"elementor elementor-5996\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-c7bb6a1 e-flex e-con-boxed e-con e-parent\" data-id=\"c7bb6a1\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-f50fb21 elementor-widget elementor-widget-heading\" data-id=\"f50fb21\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Angels Sant\u00e9 takes part in HEPHAISTOS-Pharma's \u20ac10.3M fund-raising round (FR)<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-54baaec elementor-widget elementor-widget-text-editor\" data-id=\"54baaec\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"WordSection1\">\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><strong><span class=\"OYPEnA text-decoration-none text-strikethrough-none\">HEPHAISTOS-Pharma, soci\u00e9t\u00e9 de biotechnologie d\u00e9veloppant des immunoth\u00e9rapies de nouvelle g\u00e9n\u00e9ration contre le cancer ciblant l&rsquo;immunit\u00e9 inn\u00e9e pour augmenter le taux de gu\u00e9rison des patients, a finalis\u00e9 son tour d&rsquo;amor\u00e7age de 4,5 millions d&rsquo;euros, auquel a particip\u00e9 Angels Sant\u00e9, pour financer l&rsquo;industrialisation et faire progresser son candidat principal ONCO-Boost vers la clinique.<\/span><\/strong><\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><span class=\"OYPEnA text-decoration-none text-strikethrough-none\">HEPHAISTOS-Pharma s\u00e9curise un total de 10,3 millions d&rsquo;euros aupr\u00e8s d&rsquo;investisseurs et de financements non dilutifs : 4,5 millions d&rsquo;euros de fonds d&rsquo;amor\u00e7age men\u00e9s par Elaia avec xista sciences ventures, la Fondation Fournier-Majoie, Noshaq, Angels Sant\u00e9 et Femmes Business Angels, et 5,8 millions d&rsquo;euros de financement non dilutif de l&rsquo;acc\u00e9l\u00e9rateur EIC, de Bpifrance iNov et de France 2030.<\/span><\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><span class=\"OYPEnA text-decoration-none text-strikethrough-none\">La mission d\u2019HEPHAISTOS-Pharma est d&rsquo;amener l&rsquo;immunoth\u00e9rapie \u00e0 un niveau d&rsquo;efficacit\u00e9 sup\u00e9rieur \u00e0 l\u2019existant en stimulant la r\u00e9ponse immunitaire des patients et en transformant les tumeurs froides cach\u00e9es en cibles chaudes pour notre syst\u00e8me immunitaire. Leur principal candidat, ONCO-Boost, est un immunostimulant de nouvelle g\u00e9n\u00e9ration ciblant la r\u00e9ponse immunitaire inn\u00e9e pour traiter les cancers ne r\u00e9pondant pas aux traitements actuels, y compris les immunoth\u00e9rapies d\u00e9j\u00e0 disponibles.<\/span><\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><span class=\"OYPEnA text-decoration-none text-strikethrough-none\">Selon Eric Chetaille, membre Angels Sant\u00e9 et choisi par HEPHAISTOS-Pharma pour int\u00e9grer son comit\u00e9 scientifique : \u00ab <\/span><span class=\"OYPEnA text-decoration-none text-strikethrough-none\">Des r\u00e9sultats encourageants dans des cancers agressifs ont \u00e9t\u00e9 montr\u00e9s dans des \u00e9tudes chez l\u2019animal avec ONCO-Boost seul ou en combinaison avec des immunoth\u00e9rapies de r\u00e9f\u00e9rences<\/span><span class=\"OYPEnA text-decoration-none text-strikethrough-none\"> \u00bb.<\/span><\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><span class=\"OYPEnA text-decoration-none text-strikethrough-none\">HEPHAISTOS-Pharma a \u00e9t\u00e9 cr\u00e9\u00e9e en juillet 2018 par ses 4 co-fondateurs Docteur Martine CAROFF (CSO), Professeur Jean-Marc CAVAILLON (Directeur), Alexey NOVIKOV (Responsable CMC) et Fr\u00e9d\u00e9ric CAROFF (CEO). Issue du monde acad\u00e9mique, le Dr Martine Caroff a fond\u00e9 une premi\u00e8re entreprise LPS-BioSciences en 2011. Celle-ci est sp\u00e9cialis\u00e9e dans la production de mol\u00e9cules bact\u00e9riennes, pouvant \u00eatre utilis\u00e9es comme antig\u00e8nes vaccinaux mais aussi comme immunostimulants. C&rsquo;est cette derni\u00e8re application visant \u00e0 stimuler le syst\u00e8me immunitaire et la rencontre avec le professeur Dumontet qui a donn\u00e9 lieu \u00e0 la cr\u00e9ation de l\u2019entreprise pour d\u00e9velopper un traitement contre le cancer.<\/span><\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><strong><span class=\"OYPEnA text-decoration-none text-strikethrough-none\">Le produit de ce tour de table permettra \u00e0 HEPHAISTOS d&rsquo;industrialiser son processus de fabrication et de pr\u00e9parer les phases cliniques, dans le but de faire entrer son candidat principal, ONCO-Boost, en d\u00e9veloppement clinique pour le traitement des tumeurs solides pr\u00e9sentant de forts besoins m\u00e9dicaux non satisfaits, en particulier les sarcomes.<\/span><\/strong><\/p>\n<\/div>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\">\u00a0<\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><strong><span class=\"OYPEnA text-decoration-none text-strikethrough-none\">A propos d\u2019HEPHAISTOS-Pharma<\/span><\/strong><\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><span class=\"OYPEnA text-decoration-none text-strikethrough-none\">HEPHAISTOS-Pharma est une soci\u00e9t\u00e9 de biotechnologie pr\u00e9clinique qui d\u00e9veloppe la prochaine g\u00e9n\u00e9ration d&rsquo;immunostimulants contre le cancer, r\u00e9volutionnant la stimulation immunitaire en ciblant l&rsquo;immunit\u00e9 inn\u00e9e avec une technologie unique pour l&rsquo;administration intraveineuse, ouvrant la voie \u00e0 des indications m\u00e9tastatiques et difficiles \u00e0 traiter. HEPHAISTOS-Pharma est laur\u00e9ate de bourses prestigieuses telles que Bpifrance i-Nov et l&rsquo;acc\u00e9l\u00e9rateur EIC en Europe. La soci\u00e9t\u00e9 est \u00e9galement impliqu\u00e9e dans le consortium SyStInn, dirig\u00e9 par des partenaires acad\u00e9miques, qui a re\u00e7u une subvention suppl\u00e9mentaire de 9,8 millions d&rsquo;euros du programme RHU de l&rsquo;Agence Nationale de la Recherche, qui financera en partie les essais cliniques \u00e9valuant ONCO-Boost. HEPHAISTOS-Pharma est l&rsquo;une des rares entreprises innovantes \u00e0 avoir \u00e9t\u00e9 s\u00e9lectionn\u00e9e pour son potentiel de rupture et soutenue par le p\u00f4le de comp\u00e9titivit\u00e9 Paris Saclay Cancer Cluster.<\/span><\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\">\u00a0<\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><strong><span class=\"OYPEnA text-decoration-none text-strikethrough-none\">A propos d\u2019Angels Sant\u00e9<\/span><\/strong><\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><span class=\"OYPEnA text-decoration-none text-strikethrough-none\">Angels Sant\u00e9 est le premier r\u00e9seau de Business Angels en Europe d\u00e9di\u00e9 \u00e0 la sant\u00e9 humaine et animale. Depuis sa cr\u00e9ation en 2008, elle accompagne des startups innovantes en biotech, medtech et sant\u00e9 num\u00e9rique. Sa force r\u00e9side dans son r\u00e9seau d&rsquo;investisseurs experts en sant\u00e9 ayant les connaissances n\u00e9cessaires pour fournir de la smart money \u00e0 des startups soigneusement s\u00e9lectionn\u00e9es, en leur apportant capitaux et expertise afin de soutenir leur lancement et leur d\u00e9veloppement.<\/span><\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><a class=\"OYPEnA text-decoration-underline text-strikethrough-none\" draggable=\"false\" href=\"http:\/\/www.angelssante.fr\/en\/\" target=\"_blank\" rel=\"noopener\">www.angelssante.fr<\/a><\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><span class=\"OYPEnA text-decoration-none text-strikethrough-none\">Pour tout contact :<\/span><\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><a class=\"OYPEnA text-decoration-underline text-strikethrough-none\" draggable=\"false\" href=\"mailto:info@angelssante.fr\" target=\"_blank\" rel=\"noopener\">info@angelssante.fr<\/a><\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\">\u00a0<\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\">\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>HEPHAISTOS-Pharma, soci\u00e9t\u00e9 de biotechnologie d\u00e9veloppant des immunoth\u00e9rapies de<br \/>\nnouvelle g\u00e9n\u00e9ration contre le cancer ciblant l&rsquo;immunit\u00e9 inn\u00e9e pour augmenter le taux de<br \/>\ngu\u00e9rison des patients, a finalis\u00e9 son tour d&rsquo;amor\u00e7age de 4,5 millions d&rsquo;euros, auquel a particip\u00e9<br \/>\nAngels Sant\u00e9, pour financer l&rsquo;industrialisation et faire progresser son candidat principal ONCO-<br \/>\nBoost vers la clinique.<\/p>","protected":false},"author":2,"featured_media":6013,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[6,22],"tags":[],"class_list":["post-5996","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-du-cote-de-nos-start-ups","category-mise-en-avant"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Angels Sant\u00e9 participe \u00e0 la lev\u00e9e de fonds de 10,3M\u20ac d\u2019HEPHAISTOS-Pharma - Angels Sante<\/title>\n<meta name=\"description\" content=\"HEPHAISTOS-Pharma, soci\u00e9t\u00e9 de biotechnologie d\u00e9veloppant des immunoth\u00e9rapies denouvelle g\u00e9n\u00e9ration contre le cancer ciblant l&#039;immunit\u00e9 inn\u00e9e pour augmenter le taux degu\u00e9rison des patients, a finalis\u00e9 son tour d&#039;amor\u00e7age de 4,5 millions d&#039;euros, auquel a particip\u00e9Angels Sant\u00e9, pour financer l&#039;industrialisation et faire progresser son candidat principal ONCO-Boost vers la clinique.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.angelssante.fr\/en\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Angels Sant\u00e9 participe \u00e0 la lev\u00e9e de fonds de 10,3M\u20ac d\u2019HEPHAISTOS-Pharma - Angels Sante\" \/>\n<meta property=\"og:description\" content=\"HEPHAISTOS-Pharma, soci\u00e9t\u00e9 de biotechnologie d\u00e9veloppant des immunoth\u00e9rapies denouvelle g\u00e9n\u00e9ration contre le cancer ciblant l&#039;immunit\u00e9 inn\u00e9e pour augmenter le taux degu\u00e9rison des patients, a finalis\u00e9 son tour d&#039;amor\u00e7age de 4,5 millions d&#039;euros, auquel a particip\u00e9Angels Sant\u00e9, pour financer l&#039;industrialisation et faire progresser son candidat principal ONCO-Boost vers la clinique.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.angelssante.fr\/en\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\/\" \/>\n<meta property=\"og:site_name\" content=\"Angels Sante\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.linkedin.com\/company\/angelssante\/?viewAsMember=true\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-22T10:31:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-17T10:21:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.angelssante.fr\/wp-content\/uploads\/2024\/05\/5.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"755\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"caroline\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"caroline\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\\\/\"},\"author\":{\"name\":\"caroline\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#\\\/schema\\\/person\\\/a3091af4aa360ddf6b6f0f176518b26e\"},\"headline\":\"Angels Sant\u00e9 participe \u00e0 la lev\u00e9e de fonds de 10,3M\u20ac d\u2019HEPHAISTOS-Pharma\",\"datePublished\":\"2024-05-22T10:31:04+00:00\",\"dateModified\":\"2024-07-17T10:21:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\\\/\"},\"wordCount\":688,\"publisher\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.angelssante.fr\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/5.png\",\"articleSection\":[\"Du c\u00f4t\u00e9 de nos start-ups\",\"Mise en avant\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\\\/\",\"url\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\\\/\",\"name\":\"Angels Sant\u00e9 participe \u00e0 la lev\u00e9e de fonds de 10,3M\u20ac d\u2019HEPHAISTOS-Pharma - Angels Sante\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.angelssante.fr\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/5.png\",\"datePublished\":\"2024-05-22T10:31:04+00:00\",\"dateModified\":\"2024-07-17T10:21:28+00:00\",\"description\":\"HEPHAISTOS-Pharma, soci\u00e9t\u00e9 de biotechnologie d\u00e9veloppant des immunoth\u00e9rapies denouvelle g\u00e9n\u00e9ration contre le cancer ciblant l'immunit\u00e9 inn\u00e9e pour augmenter le taux degu\u00e9rison des patients, a finalis\u00e9 son tour d'amor\u00e7age de 4,5 millions d'euros, auquel a particip\u00e9Angels Sant\u00e9, pour financer l'industrialisation et faire progresser son candidat principal ONCO-Boost vers la clinique.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.angelssante.fr\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/5.png\",\"contentUrl\":\"https:\\\/\\\/www.angelssante.fr\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/5.png\",\"width\":2000,\"height\":755},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.angelssante.fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Angels Sant\u00e9 participe \u00e0 la lev\u00e9e de fonds de 10,3M\u20ac d\u2019HEPHAISTOS-Pharma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#website\",\"url\":\"https:\\\/\\\/www.angelssante.fr\\\/\",\"name\":\"Angel Sante\",\"description\":\"Premier r\u00e9seau de Business Angels en Europe d\u00e9di\u00e9 \u00e0 la sant\u00e9.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.angelssante.fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#organization\",\"name\":\"Angel Sante\",\"url\":\"https:\\\/\\\/www.angelssante.fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.angelssante.fr\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/logo4-pdf.jpg\",\"contentUrl\":\"https:\\\/\\\/www.angelssante.fr\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/logo4-pdf.jpg\",\"width\":685,\"height\":290,\"caption\":\"Angel Sante\"},\"image\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/angelssante\\\/?viewAsMember=true\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#\\\/schema\\\/person\\\/a3091af4aa360ddf6b6f0f176518b26e\",\"name\":\"caroline\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/99fada4791cc438694b17db6c935e6be622048c73401455708bb9858b4a4cd29?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/99fada4791cc438694b17db6c935e6be622048c73401455708bb9858b4a4cd29?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/99fada4791cc438694b17db6c935e6be622048c73401455708bb9858b4a4cd29?s=96&d=mm&r=g\",\"caption\":\"caroline\"},\"url\":\"https:\\\/\\\/www.angelssante.fr\\\/en\\\/author\\\/caroline\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Angels Sant\u00e9 participe \u00e0 la lev\u00e9e de fonds de 10,3M\u20ac d\u2019HEPHAISTOS-Pharma - Angels Sante","description":"HEPHAISTOS-Pharma, soci\u00e9t\u00e9 de biotechnologie d\u00e9veloppant des immunoth\u00e9rapies denouvelle g\u00e9n\u00e9ration contre le cancer ciblant l'immunit\u00e9 inn\u00e9e pour augmenter le taux degu\u00e9rison des patients, a finalis\u00e9 son tour d'amor\u00e7age de 4,5 millions d'euros, auquel a particip\u00e9Angels Sant\u00e9, pour financer l'industrialisation et faire progresser son candidat principal ONCO-Boost vers la clinique.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.angelssante.fr\/en\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\/","og_locale":"en_US","og_type":"article","og_title":"Angels Sant\u00e9 participe \u00e0 la lev\u00e9e de fonds de 10,3M\u20ac d\u2019HEPHAISTOS-Pharma - Angels Sante","og_description":"HEPHAISTOS-Pharma, soci\u00e9t\u00e9 de biotechnologie d\u00e9veloppant des immunoth\u00e9rapies denouvelle g\u00e9n\u00e9ration contre le cancer ciblant l'immunit\u00e9 inn\u00e9e pour augmenter le taux degu\u00e9rison des patients, a finalis\u00e9 son tour d'amor\u00e7age de 4,5 millions d'euros, auquel a particip\u00e9Angels Sant\u00e9, pour financer l'industrialisation et faire progresser son candidat principal ONCO-Boost vers la clinique.","og_url":"https:\/\/www.angelssante.fr\/en\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\/","og_site_name":"Angels Sante","article_publisher":"https:\/\/www.linkedin.com\/company\/angelssante\/?viewAsMember=true","article_published_time":"2024-05-22T10:31:04+00:00","article_modified_time":"2024-07-17T10:21:28+00:00","og_image":[{"width":2000,"height":755,"url":"https:\/\/www.angelssante.fr\/wp-content\/uploads\/2024\/05\/5.png","type":"image\/png"}],"author":"caroline","twitter_card":"summary_large_image","twitter_misc":{"Written by":"caroline","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.angelssante.fr\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\/#article","isPartOf":{"@id":"https:\/\/www.angelssante.fr\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\/"},"author":{"name":"caroline","@id":"https:\/\/www.angelssante.fr\/#\/schema\/person\/a3091af4aa360ddf6b6f0f176518b26e"},"headline":"Angels Sant\u00e9 participe \u00e0 la lev\u00e9e de fonds de 10,3M\u20ac d\u2019HEPHAISTOS-Pharma","datePublished":"2024-05-22T10:31:04+00:00","dateModified":"2024-07-17T10:21:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.angelssante.fr\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\/"},"wordCount":688,"publisher":{"@id":"https:\/\/www.angelssante.fr\/#organization"},"image":{"@id":"https:\/\/www.angelssante.fr\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\/#primaryimage"},"thumbnailUrl":"https:\/\/www.angelssante.fr\/wp-content\/uploads\/2024\/05\/5.png","articleSection":["Du c\u00f4t\u00e9 de nos start-ups","Mise en avant"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.angelssante.fr\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\/","url":"https:\/\/www.angelssante.fr\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\/","name":"Angels Sant\u00e9 participe \u00e0 la lev\u00e9e de fonds de 10,3M\u20ac d\u2019HEPHAISTOS-Pharma - Angels Sante","isPartOf":{"@id":"https:\/\/www.angelssante.fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.angelssante.fr\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\/#primaryimage"},"image":{"@id":"https:\/\/www.angelssante.fr\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\/#primaryimage"},"thumbnailUrl":"https:\/\/www.angelssante.fr\/wp-content\/uploads\/2024\/05\/5.png","datePublished":"2024-05-22T10:31:04+00:00","dateModified":"2024-07-17T10:21:28+00:00","description":"HEPHAISTOS-Pharma, soci\u00e9t\u00e9 de biotechnologie d\u00e9veloppant des immunoth\u00e9rapies denouvelle g\u00e9n\u00e9ration contre le cancer ciblant l'immunit\u00e9 inn\u00e9e pour augmenter le taux degu\u00e9rison des patients, a finalis\u00e9 son tour d'amor\u00e7age de 4,5 millions d'euros, auquel a particip\u00e9Angels Sant\u00e9, pour financer l'industrialisation et faire progresser son candidat principal ONCO-Boost vers la clinique.","breadcrumb":{"@id":"https:\/\/www.angelssante.fr\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.angelssante.fr\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.angelssante.fr\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\/#primaryimage","url":"https:\/\/www.angelssante.fr\/wp-content\/uploads\/2024\/05\/5.png","contentUrl":"https:\/\/www.angelssante.fr\/wp-content\/uploads\/2024\/05\/5.png","width":2000,"height":755},{"@type":"BreadcrumbList","@id":"https:\/\/www.angelssante.fr\/angels-sante-participe-a-la-levee-de-fonds-de-103me-de-hephaistos-pharma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.angelssante.fr\/"},{"@type":"ListItem","position":2,"name":"Angels Sant\u00e9 participe \u00e0 la lev\u00e9e de fonds de 10,3M\u20ac d\u2019HEPHAISTOS-Pharma"}]},{"@type":"WebSite","@id":"https:\/\/www.angelssante.fr\/#website","url":"https:\/\/www.angelssante.fr\/","name":"Angel Sante","description":"Premier r\u00e9seau de Business Angels en Europe d\u00e9di\u00e9 \u00e0 la sant\u00e9.","publisher":{"@id":"https:\/\/www.angelssante.fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.angelssante.fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.angelssante.fr\/#organization","name":"Angel Sante","url":"https:\/\/www.angelssante.fr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.angelssante.fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.angelssante.fr\/wp-content\/uploads\/2024\/02\/logo4-pdf.jpg","contentUrl":"https:\/\/www.angelssante.fr\/wp-content\/uploads\/2024\/02\/logo4-pdf.jpg","width":685,"height":290,"caption":"Angel Sante"},"image":{"@id":"https:\/\/www.angelssante.fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/angelssante\/?viewAsMember=true"]},{"@type":"Person","@id":"https:\/\/www.angelssante.fr\/#\/schema\/person\/a3091af4aa360ddf6b6f0f176518b26e","name":"caroline","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/99fada4791cc438694b17db6c935e6be622048c73401455708bb9858b4a4cd29?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/99fada4791cc438694b17db6c935e6be622048c73401455708bb9858b4a4cd29?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/99fada4791cc438694b17db6c935e6be622048c73401455708bb9858b4a4cd29?s=96&d=mm&r=g","caption":"caroline"},"url":"https:\/\/www.angelssante.fr\/en\/author\/caroline\/"}]}},"_links":{"self":[{"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/posts\/5996","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/comments?post=5996"}],"version-history":[{"count":8,"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/posts\/5996\/revisions"}],"predecessor-version":[{"id":6004,"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/posts\/5996\/revisions\/6004"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/media\/6013"}],"wp:attachment":[{"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/media?parent=5996"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/categories?post=5996"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/tags?post=5996"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}